✦ LIBER ✦

Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin®): a prospective study of 50 patients

✍ Scribed by A. BOREL-DERLON; A. B. FEDERICI; V. ROUSSEL-ROBERT; J. GOUDEMAND; C. A. LEE; I. SCHARRER; C. ROTHSCHILD; E. BERNTORP; C. HENRIET; Z. TELLIER; F. BRIDEY; P. M. MANNUCCI

Book ID: 109152135
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 591 KB
Volume: 5
Category: Article
ISSN: 1538-7933
DOI: 10.1111/j.1538-7836.2007.02562.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of Optivate®, a high-pu

Pharmacokinetics of Optivate®, a high-purity concentrate of factor VIII with von Willebrand factor, in patients with severe haemophilia A

✍ A. DMOSZYNSKA; A. HELLMANN; T. BAGLIN; D. O’SHAUGNESSY; J. TRELINSKI; K. KULICZK 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB

Clinical efficacy and safety of the fact

Clinical efficacy and safety of the factor VIII/von Willebrand factor concentrate BIOSTATE® in patients with von Willebrand’s disease: a prospective multi-centre study

✍ S. DUNKLEY; R. I. BAKER; M. PIDCOCK; J. PRICE; M. SELDON; M. SMITH; A. STREET; D 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

Experience with Optivate®, a new high pu

Experience with Optivate®, a new high purity concentrate of factor VIII with von Willebrand factor, in patients undergoing surgery

✍ C. R. M. HAY; A. HELLMANN; A. DMOSZYNSKA; T. BAGLIN; D. O’SHAUNESSEY; M. MAKRIS; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

Treatment and prevention of acute bleedi

Treatment and prevention of acute bleedings in von Willebrand disease – efficacy and safety of Wilate®, a new generation von Willebrand factor/factor VIII concentrate

✍ E. BERNTORP; J. WINDYGA; THE EUROPEAN WILATE STUDY GROUP 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Efficacy and safety of a high purity, do

Efficacy and safety of a high purity, double virus inactivated factor VIII/von Willebrand factor concentrate (Biostate®) in patients with von Willebrand disorder requiring invasive or surgical procedures

✍ J. SHORTT; S. DUNKLEY; K. RICKARD; R. BAKER; A. STREET 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB

Clinical assessment of Optivate®, a high

Clinical assessment of Optivate®, a high-purity concentrate of factor VIII with von Willebrand factor, in the management of patients with haemophilia A

✍ A. DMOSZYNSKA; K. KULICZKOWSKI; A. HELLMANN; J. TRELINSKI; J. KLOCZKO; T. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB